Nurse Practitioner Program year 2025 Reported 2021–2025 Source: CMS Open Payments, 2026 publication

Patricia Delgado

Nurse Practitioner St Petersburg, FL Nurse Practitioner

NPI 1417329517 CMS profile 10680789

9079 4Th St N, St Petersburg, FL 33702

Open in the dashboard

General payments

$20,532

236 records reported · program years 2021–2025

Research payments

$0

Paid to them · None reported · program years 2021–2025

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$94,144 paid to institutions, not to them · program years 2021–2022

Through program year 2025, Patricia Delgado of St Petersburg, FL is reported in the CMS Open Payments database as having received $20,532 across 236 general payments and $0 in research payments paid to them. Separately, studies naming them as principal investigator received $94,144 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 99th percentile of Nurse Practitioner profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

5 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $8,492 37
2024 General $1,891 26
2023 General $3,592 38
2022 General $4,148 76
2021 General $2,408 59

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Patricia Delgado
  • Nurse Practitioner median
  • Middle half of Nurse Practitioner
  • National median

In program year 2025, general payments to Patricia Delgado were reported at $8,492. Among 41,044 Nurse Practitioner profiles paid that year, the median was $174 and the middle half received between $55 and $557.

Show as a table
Year Patricia Delgado Nurse Practitioner median Middle half National median
2019 $0 $50 $22–$97 $163
2020 $0 $40 $16–$108 $114
2021 $2,408 $135 $40–$426 $132
2022 $4,148 $152 $48–$470 $149
2023 $3,592 $166 $54–$529 $160
2024 $1,891 $173 $55–$556 $164
2025 $8,492 $174 $55–$557 $169

Breakdown

Who paid General payments · program years 2021–2025
  1. Incyte Corporation $6,720 16 payments
  2. Novartis Pharmaceuticals Corporation $1,942 48 payments
  3. AbbVie, Inc. $1,807 32 payments
  4. Janssen Biotech, Inc. $1,060 24 payments
  5. Sun Pharmaceutical Industries Inc. $927 13 payments
  6. Regeneron Healthcare Solutions, Inc. $902 14 payments
  7. Genzyme Corporation $811 13 payments
  8. E.R. Squibb & Sons, L.L.C. $578 7 payments
  9. Journey Medical Corporation $571 8 payments
  10. Lilly USA, LLC $507 6 payments
  11. Other $4,709 55 payments

Every payment, record by record

What the payments were for General payments · program years 2021–2025
  1. Food and Beverage $13,201 218 payments
  2. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $2,880 1 payment
  3. Travel and Lodging $2,089 8 payments
  4. Consulting Fee $2,038 3 payments
  5. Education $324 6 payments
Products named General payments · program years 2021–2025
  1. TREMFYA $1,268 20 payments
  2. COSENTYX Dermatology $1,266 15 payments
  3. Winlevi $854 9 payments
  4. DUPIXENT Inflammation And Immunology $763 13 payments
  5. DUPIXENT Immunology $729 14 payments
  6. RINVOQ $527 7 payments
  7. COSENTYX Immunology $465 27 payments
  8. VRAYLAR $426 4 payments
  9. SOTYKTU $331 4 payments
  10. Absorica LD $307 3 payments
  11. Other $6,922 124 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Records

236 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Nurse Practitioner in Florida

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record